 |
The future for drug developers is defined by how effectively they adopt innovative strategies and new technologies, while navigating industry challenges and complexities. That’s why the PPD clinical research business of Thermo Fisher Scientific surveyed 150 leaders at biotech and pharmaceutical organizations around the globe to assess trends in drug discovery and development. Respondents shared the therapeutic areas in their pipelines, barriers to bringing drugs to market, innovations that are driving transformation, and attitudes toward key topics such as outsourcing, patient recruitment, diversity, decentralized trials, and more. In our second annual report, you’ll go beyond the data to learn what these insights mean for drug developers across the globe, and how you can prepare to successfully navigate the evolving drug development landscape. Discover what industry leaders are facing today, and how their outlook on pharmaceutical research and development is pushing the industry forward. The online survey was conducted on behalf of the PPD clinical research business of Thermo Fisher Scientific by Life Science Strategy Group (LSSG) using its proprietary panel of more than 70,000 life science stakeholders and biopharma/biotech industry outsourcing decision makers and its affiliated APAC partner’s respondent panel. |
